A call for research proposals (deadline 31 March 2020) was announced by the Innovative Medicines Initiative (IMI) on 3 March 2020 that aims to support projects that develop treatments and diagnostics to better tackle the COVID-19 outbreak and to increase preparedness for future possible outbreaks.
The IMI is a public-private partnership between the EU and the pharmaceutical industry through its association EFPIA.
The European Commission funds IMI through Horizon 2020 and will contribute up to €45 million to this call. A commitment of a similar scale is expected from the pharmaceutical industry so that the total investment could reach up to €90 million.
The call could be found here https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-21